Day 2, Session VIII
Clinical Stage Drugs, moderated by Steven C. Schachter, MD, Professor of Neurology, Harvard Medical School, Chief Academic Officer, Consortia for Improving Medicine with Innovation and Technology
This session includes:
- Ultragenyx Pharmaceutical Inc. | UX007G
Emil D. Kakkis, MD, PhD, CEO, Ultragenyx Pharmaceutical Inc.
Starts at 1:07
- Alexza Pharmaceuticals | Inhaled Alprazolam
James V. Cassella, PhD, CSO and Executive Vice President, R&D, Alexza Pharmaceuticals, Inc.
Starts at 12:53
- GW Pharmaceuticals | Epidiolex in Pediatric Epilepsy
Alice Mead, JD, Vice President, Professional Relations
Starts at 23:51
- Insero Health | Huperzine Update
Stephen D. Collins, MD, PhD, President and CEO, Insero Health, Inc.
Starts at 33:30
- Marinus Pharmaceuticals, Inc. | Ganaxolone
Gail M. Farfel, PhD, Chief Clinical Development and Regulatory Officer, Marinus Pharmaceuticals, Inc.
Starts at 42:22
- SK LifeScience, Inc. | YKP 3089
Christopher Gallen, MD, PhD, President and CEO, SK Biopharmaceuticals | SK Life Sciences
Starts at 53:32
- UCB | Brivaracetam Update
Joseph D'Souza, Senior Global Medical Director, UCB
Starts at 1:05:08
- Vertex Pharmaceuticals | VX-765
Jacqueline French, MD, Professor of Neurology, New York University, Co-Director Epilepsy Research and Epilepsy Clinical Trials, NYU Comprehensive Epilepsy Center
Starts at 1:13:53
- Sapienza University, University of Utrecht | Pitolisant, a Histamine 3 Receptor Antagonist, in the Human Photosensitivity Model
Dorothee Kasteleijn- Nolst Trenité, Prof Neuroscience at Sapienza University, Rome, Italy, Sr. Researcher Medical Genetics, University of Utrecht, The Netherlands
Starts at 1:28:55
- IzumiBiosciences, LLC | Elacridar
Ton Bunt, MD MBA, President, CEO & Founder, IzumiBiosciences, LLC
Starts at 1:39:20
- Brabant Pharma | 22 Years of Clinical Data using Low-dose Fenfluramine to Treat Dravet Syndrome
Rick Stewart, Director, Brabant Pharma
Starts at 1:50:10
- Realm of Caring Foundation | Charlotte's Web: The Facts and the Future
Paige Figi, Spokesperson and Co-Founder
Starts at 2:00:57
<< Previous Video:
Day 2, New Directions and Opportunities in Epilepsy Research